Despite the fact that marihuana is one of the major drugs of abuse, relatively little is known regarding the mechanism by which its principal psychoactive constituent, delta 9- tetrahydrocannabinol (THC), produces its subjective effects. It is hypothesized that the behavioral effects of delta 9-THC represent a composite of effects that arise from the actions of cannabinoids produce these behavioral effects. The emphasis will be directed toward determining whether behavioral effects of delta 9-THC are mediated either through a specific cannabinoid receptor or through membrane perturbation. Therefore, a major objective will be to determine whether the pharmacological profile of cannabinoids can be separated into individual behavioral components by evaluating synthetic analogs for their ability to produce motor hypoactivity, hypothermia, catalepsy and antinociception in mice, stimulus generalization to delta 9-THC in delta 9-THC trained rats and monkeys and behavioral effects (static ataxia) in dogs. Partition coefficients of the analogs will be determined as well as the degree to which the analogs cause membrane perturbation. A correlation between the pharmacological profile of the analogs and their actions on these biochemical systems should provide insight into their mechanism of action. In addition, efforts will be made to determine whether or not specific cannabinoid receptor exists. Attempts will be made to establish an in vitro binding assay by synthesizing radiolabeled ligands that regain behavioral activity but are less lipophilic than delta 9-THC. These radiolabeled ligands will include potential photoaffinity labels (azido compounds) as well as nitrogen mustards. Efforts will also be made to isolate specific binding sites by affinity chromatography. In addition, attempts will be made to develop a specific cannabinoid antagonist. The analogs that exhibit little or no agonistic activity will be evaluated in the above mentioned behavioral tests as potential antagonists of delta 9-THC. The results of these experiments will provide important insights into the mechanism by which cannabinoids produce their central effects. Identification of the neurochemical processes involved in the subjective effects of cannabinoids will lead to a better understanding of the etiology of recreational use of marihuana and may lead to the development of an effective deterrent. In addition, identification of the biochemical events associated with cannabinoid behavioral effects may provide insights into the processes involved in mental abberations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003672-08
Application #
3208235
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1984-09-01
Project End
1992-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Mitjavila, Jose; Yin, Danielle; Kulkarni, Pushkar M et al. (2018) Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons. Pharmacol Res 129:475-481
Barrus, Daniel G; Lefever, Timothy W; Wiley, Jenny L (2018) Evaluation of reinforcing and aversive effects of voluntary ?9-tetrahydrocannabinol ingestion in rats. Neuropharmacology 137:133-140
Kevin, Richard C; Lefever, Timothy W; Snyder, Rodney W et al. (2018) Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18. Drug Test Anal 10:137-147
Marusich, Julie A; Wiley, Jenny L; Lefever, Timothy W et al. (2018) Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists. Neuropharmacology 134:73-81
Wiley, Jenny L; Owens, R Allen; Lichtman, Aron H (2018) Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids. Curr Top Behav Neurosci 39:153-173
Wiley, Jenny L; Lefever, Timothy W; Marusich, Julie A et al. (2017) Comparison of the discriminative stimulus and response rate effects of ?9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats. Drug Alcohol Depend 172:51-59
Owens, Robert A; Mustafa, Mohammed A; Ignatowska-Jankowska, Bogna M et al. (2017) Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice. Neuropharmacology 125:80-86
Gamage, Thomas F; Farquhar, Charlotte E; Lefever, Timothy W et al. (2017) The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators. Neuropharmacology 125:365-375
Thomas, Brian F; Lefever, Timothy W; Cortes, Ricardo A et al. (2017) Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences. J Pharmacol Exp Ther 361:162-171
Wiley, Jenny L; Marusich, Julie A; Thomas, Brian F (2017) Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids. Curr Top Behav Neurosci 32:231-248

Showing the most recent 10 out of 284 publications